Trends in HIV diagnoses in Ontario, 2000­2004 Robert S. Remis, Jane Njihia, Carol Swantee, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit,

Slides:



Advertisements
Similar presentations
Sexually transmitted infections: epidemiological evidence of need Dr Kirsty Foster Consultant in Health Protection Public Health England Centre, North.
Advertisements

Satellite meeting on the STARHS HIV diagnostic assay in association with the 15th International AIDS Conference July 2004, Bangkok, Thailand Robert S.
Increased routine screening for syphilis and falling syphilis incidence in HIV positive and HIV negative men who have sex with men: implications for syphilis.
Trends in HIV incidence in the Omega cohort of men who have sex with men (MSM) in Montreal: October February 2002 Robert S, Remis, Michel Alary,
Syphilis Trends in the United States James D. Heffelfinger, MD, MPH Epidemiology and Surveillance Branch, DSTD Centers for Disease Control and Prevention.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Epidemiology of HIV-2 infection in the U.S, Lata Kumar MS, MPH Richard Selik MD Division of HIV/AIDS Prevention National Center for HIV/AIDS,
Ecological Model for HIV Risk in MSM Stage of Epidemic Individual Community Public Policy Network Level of Risks Source: Baral and Beyrer, 2006.
SOUTH CAROLINA EPIDEMIOLOGIC PROFILE Data available in an Integrated Epidemiologic Profile Core Epi Section Socio-demographic characteristics of.
History of the HIV Endemic Task Force (HETF) and its Activities: Retracing the Footsteps Presenters: Esther Tharao and Dr. Robert Remis, on behalf of HETF.
HIV Surveillance – Persons Who Inject Drugs National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
Directions in national immigrant health National Symposium on Immigrant Health Citizenship and Immigration Canada Citoyenneté et Immigration Canada Medical.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario Robert S. Remis MD Department.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario: Update to 2002 Robert S.
1 HIV/STD Trends in Texas Sharon K. Melville, M.D., M.P.H. Texas Department of State Health Services Texas Public Health Association April 22, 2010.
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
HIV/AIDS Epidemiology Update February 2009 Dr Nigel Dickson Director, AIDS Epidemiology Group Department of Preventive and Social Medicine University of.
Description of fracture with endocrine therapy use in older breast cancer survivors in a population-based setting Taryn Becker 123, Geoff Anderson 123,
HIV/AIDS in Michigan January 1, 2010 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases Bureau.
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
Trends in high-risk sexual behaviour among homosexual men participating in the AIDSVAX ® B/B vaccine trial in Canada: Results to 12 months Robert S. Remis,
Overview of the State of the HIV Epidemic in Canada Regional Session on USA and Canada XIX International AIDS Conference Howard Njoo MD, MHSc, FRCPC Director-General.
HIV infection among men who have sex with men in Ontario: Analysis by race/ethnicity Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring.
Epidemiology of Hepatitis C Infection in Canada Robert S. Remis MD, MPH, FRCPC Department of Public Health Sciences University of Toronto 1st Canadian.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
TESTING FOR HIV TO PREVENT MOTHER-INFANT TRANSMISSION POLICY CONSIDERATIONS ROBERT S. REMIS MD DEPARTMENT OF PUBLIC HEALTH SCIENCES, UNIVERSITY OF TORONTO.
HIV/AIDS among Women in Texas Enhanced Perinatal Surveillance May 30, 2007 Nita Ngo, MPH.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Page 1 Increasing rates of earlier antiretroviral treatment associated with elevated levels of optimal virologic response among HIV-positive illicit drug.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Bias in estimates of HIV incidence based on the detuned assay: A proposed solution Robert S Remis, Robert WH Palmer, Janet M Raboud Department of Public.
Epidemiologic overview of HIV/AIDS in Ontario and Toronto: 2004 update Robert S. Remis MD, MPH, FRCPC, Maraki Fikre Merid BSc Ontario HIV Epidemiologic.
Using the detuned assay to determine HIV incidence in Ontario: Results and methodologic perspectives Robert S. Remis, Carol Major, Carol Swantee, Margaret.
Increasing HIV testing among pregnant women: Results from the Ontario HIV seroprevalence study Robert S. Remis, Carol Swantee, Maraki Fikre Merid, Robert.
Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2012 Living.
Trends in HIV incidence in Ontario based on the detuned assay: Update to October 2000 Robert S. Remis, Carol Major, Carol Swantee, Margaret Fearon, Evelyn.
Trends in HIV incidence and sexual behaviour in a cohort of men who have sex with men (MSM) in Montreal, Robert S. Remis, Michel Alary, Joanne.
Primary HIV-1 drug resistance in Canada: Updated results from the Canadian HIV Strain and Drug Resistance Surveillance Program Canadian HIV Strain and.
HIV infection among persons in Ontario infected through heterosexual contact Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit.
Trends in HIV incidence in Ontario based on the detuned assay: Update to December 2002 Robert S. Remis, Carol Major, Carol Swantee, Margaret Fearon, Robert.
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2004 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
Annual Epidemiological Spotlight on HIV in London: 2014 data Field Epidemiology Services PHE Publications gateway number
Increasing Incidence of Gonorrhea in California (the talk formerly known as: “Gonorrhea Drips on in California”) Michael C Samuel 1, Virginia Loo 1, Denise.
Laboratory Enhancement Study: Using the detuned assay to determine HIV incidence in Ontario October 1999 – July 2000 Robert S. Remis, Carol Major, Carol.
The HIV epidemic in Ontario: 2004 update Robert S. Remis, MD, MPH, FRCPC Ontario HIV Epidemiologic Monitoring Unit Department of Public Health Sciences,
Marked increase in first-time HIV diagnoses in Ontario, 2002.
Inequalities in Sexual Health. Update on HIV and STIs in men who have sex with men in London Field Epidemiology Services PHE Publications gateway number:
HIV Surveillance in Women National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
1 National HIV/AIDS Commission, Barbados HIV/AIDS Research Symposium Researching who? Engaging communities in the response to HIV Winston Husbands, PhD.
Abstract #TUPDE202: Collaboration and Cross Training between Health and Correctional Services Leads to More Integrated Services for PHAs in Prison: Poster.
Uptake of HIV testing among pregnant women in Ontario: Results from the HIV seroprevalence study to December 2000 Robert S. Remis, Carol Major, Margaret.
The HIV epidemic in Ontario: An epidemiologic update Robert S. Remis, MD, MPH, FRCPC, Department of Public Health Sciences, University of Toronto Presentation.
Update on epidemiology of HIV in New Zealand Dr Sue McAllister AIDS Epidemiology Group (AEG) University of Otago Dunedin HIV Women’s Seminar Auckland,
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
The Indigenous HIV/AIDS Epidemic: Are We Invisible?
Olga Varetska International HIV/AIDS Alliance in Ukraine
Persistent Contribution of Substance Abuse to Excess Mortality Among Persons with AIDS in New York City, Pfeiffer MR, Hanna DB, Begier EM,
HIV Diagnosis and the Cascade of Care in Ontario
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Brief overview of HIV among MSM in the EU/EEA
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2003 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS Surveillance in Europe
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Epidemiologic Update on the HIV Epidemic in Ontario
Health Protection Surveillance Centre
Key Affected Populations
3rd Annual Health Policy Conference – Ryerson University
Trends in HIV incidence and sexual behaviour among a cohort of men who have sex with men (MSM) in Montreal: Robert S. Remis, Michel Alary, Joanne.
Expert Group on HIV/STI
Presentation transcript:

Trends in HIV diagnoses in Ontario, 2000­2004 Robert S. Remis, Jane Njihia, Carol Swantee, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit, Public Health Sciences, University of Toronto ; HIV Laboratory, Ontario Ministry of Health; Public Health Agency of Canada 14th Annual Canadian Conference on HIV/AIDS Research Vancouver, BC, May 13, 2005

instructional media centre, Laboratories Branch Background In Ontario, essentially all HIV diagnostic testing is conducted at the HIV Laboratory and regional labs In Ontario, essentially all HIV diagnostic testing is conducted at the HIV Laboratory and regional labs We use diagnostic test results to monitor the HIV epidemic on an ongoing basis We use diagnostic test results to monitor the HIV epidemic on an ongoing basis Since 2000, we observed a substantial increase in the number of new HIV diagnoses Since 2000, we observed a substantial increase in the number of new HIV diagnoses Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Study objectives 1. To characterize trends in new HIV diagnoses in Ontario 2. To determine to what extent observed trends due to testing artefact Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Methods Examined first-time HIV-positive and total HIV tests from 1985 to 2004, with particular attention to years 2000 to 2004 Examined first-time HIV-positive and total HIV tests from 1985 to 2004, with particular attention to years 2000 to 2004 First-time HIV positive: confirmed positive with no previous positive result identified and no evidence of previous positive test in Ontario First-time HIV positive: confirmed positive with no previous positive result identified and no evidence of previous positive test in Ontario Adjusted exposure category using data on risk factors from Laboratory Enhancement Study Adjusted exposure category using data on risk factors from Laboratory Enhancement Study Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Methods Based on the observed pattern, defined the baseline year as 2000 Based on the observed pattern, defined the baseline year as 2000 Compared HIV test results for 2004 to those in earlier years by sex, exposure category and reason for testing Compared HIV test results for 2004 to those in earlier years by sex, exposure category and reason for testing Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Number of HIV diagnoses by sex Ontario, Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Number of HIV diagnoses by sex Ontario, Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Number of HIV diagnoses by exposure category, Ontario, Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Possible explanations Artefact related to: Artefact related to: Impact of immigration testing in 2002 Impact of immigration testing in 2002 Impact of increased prenatal testing Impact of increased prenatal testing General increase in HIV testing General increase in HIV testing Real increase related to new HIV infection Real increase related to new HIV infection Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Impact of HIV diagnoses related to prenatal and immigration HIV testing, 2004 versus 2000 Dr. Robert S. Remis Public Health Sciences, University of Toronto MaleFemale Total Excess HIV Excess # Visa Prenatal Total Excess % Visa35% 28% 32% Prenatal 17% 7% Total35% 45% 39%

instructional media centre, Laboratories Branch HIV tests versus HIV diagnoses MSM, Ontario Dr. Robert S. Remis Public Health Sciences, University of Toronto TestsIncreaseHIV diagIncrease ,987 Referent 446 Referent ,320 7% 448 0% ,348 28% % ,075 32% % ,378 44% %

instructional media centre, Laboratories Branch HIV tests versus HIV diagnoses HIV-endemic, Ontario, Dr. Robert S. Remis Public Health Sciences, University of Toronto TestsIncreaseHIV diagIncrease ,789 Referent 180 Referent ,308 8% % ,706 43% % ,631 57% % ,355 67% %

instructional media centre, Laboratories Branch HIV tests versus HIV diagnoses heterosexual, Ontario, Dr. Robert S. Remis Public Health Sciences, University of Toronto TestsIncreaseHIV diagIncrease ,082 Referent 146 Referent ,517 7% % ,143 35% % ,537 39% % ,153 51% %

instructional media centre, Laboratories Branch Summary of findings From 2000 to 2004, marked increase in HIV diagnoses, especially in heterosexual (+66%), MSM (+42%) and endemic (+33%) exposure categories From 2000 to 2004, marked increase in HIV diagnoses, especially in heterosexual (+66%), MSM (+42%) and endemic (+33%) exposure categories Increases partly related to increases in testing for prenatal and immigration, especially in women and persons from endemic countries Increases partly related to increases in testing for prenatal and immigration, especially in women and persons from endemic countries Testing increased in all three exposure categories Testing increased in all three exposure categories Endemic:  testing >>  HIV diagnoses Endemic:  testing >>  HIV diagnoses MSM:  testing   HIV diagnoses MSM:  testing   HIV diagnoses Heterosexual:  testing <<  HIV diagnoses Heterosexual:  testing <<  HIV diagnoses Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Study limitations Data on reason for testing indicating visa may be incomplete Data on reason for testing indicating visa may be incomplete Data on HIV diagnoses and testing based on adjustments using weights from LES; subject to uncertainty Data on HIV diagnoses and testing based on adjustments using weights from LES; subject to uncertainty Limit data on characteristics of subpopulations who present for HIV testing, who are “new” and who are more frequent testers Limit data on characteristics of subpopulations who present for HIV testing, who are “new” and who are more frequent testers Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Conclusions Among persons from HIV-endemic countries, increase likely related immigration testing policy begun in Jan 2002 Among persons from HIV-endemic countries, increase likely related immigration testing policy begun in Jan 2002 MSM: Testing and diagnoses increased about the same, but not necessarily reassuring MSM: Testing and diagnoses increased about the same, but not necessarily reassuring Increased testing frequency should not increase number of diagnoses Increased testing frequency should not increase number of diagnoses If epidemic controlled, new persons testing yields few additional diagnoses (“exhaust the prevalent cases”) If epidemic controlled, new persons testing yields few additional diagnoses (“exhaust the prevalent cases”) Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Conclusions Heterosexual: Increased diagnoses >> increased tests suggests substantial continued HIV transmission Heterosexual: Increased diagnoses >> increased tests suggests substantial continued HIV transmission Study in Toronto and Ottawa to better understand apparent increase in HIV infection among persons infected heterosexually Study in Toronto and Ottawa to better understand apparent increase in HIV infection among persons infected heterosexually HIV epidemic in Ontario still unstable and evolving HIV epidemic in Ontario still unstable and evolving Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Acknowledgements Frank McGee, AIDS Bureau, Ontario Ministry of Health and Long Term Care (MOHLTC) Frank McGee, AIDS Bureau, Ontario Ministry of Health and Long Term Care (MOHLTC) Carol Major, formerly of HIV Laboratory, MOHLTC Carol Major, formerly of HIV Laboratory, MOHLTC OHTN ( ) and Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada ( ) for funding LES OHTN ( ) and Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada ( ) for funding LES